Literature DB >> 24950692

Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.

Iryna Sutter1, Rebekka Park2, Alaa Othman3, Lucia Rohrer1, Thorsten Hornemann1, Markus Stoffel2, Olivier Devuyst4, Arnold von Eckardstein5.   

Abstract

Sphingosine-1-phosphate (S1P) mediates several cytoprotective functions of HDL. apoM acts as a S1P binding protein in HDL. Erythrocytes are the major source of S1P in plasma. After glomerular filtration, apoM is endocytosed in the proximal renal tubules. Human or murine HDL elicited time- and dose-dependent S1P efflux from erythrocytes. Compared with HDL of wild-type (wt) mice, S1P efflux was enhanced in the presence of HDL from apoM transgenic mice, but not diminished in the presence of HDL from apoM knockout (Apom(-/-)) mice. Artificially reconstituted and apoM-free HDL also effectively induced S1P efflux from erythrocytes. S1P and apoM were not measurable in the urine of wt mice. Apom(-/-) mice excreted significant amounts of S1P. apoM was detected in the urine of mice with defective tubular endocytosis because of knockout of the LDL receptor-related protein, chloride-proton exchanger ClC-5 (Clcn5(-/-)), or the cysteine transporter cystinosin. Urinary levels of S1P were significantly elevated in Clcn5(-/-) mice. In contrast to Apom(-/-) mice, these mice showed normal plasma concentrations for apoM and S1P. In conclusion, HDL facilitates S1P efflux from erythrocytes by both apoM-dependent and apoM-independent mechanisms. Moreover, apoM facilitates tubular reabsorption of S1P from the urine, however, with no impact on S1P plasma concentrations.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  chloride-proton exchanger ClC5; cystinosin; high density lipoprotein; kidney; megalin

Mesh:

Substances:

Year:  2014        PMID: 24950692      PMCID: PMC4109767          DOI: 10.1194/jlr.M050021

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

Review 1.  Molecular and physiological functions of sphingosine 1-phosphate transporters.

Authors:  Tsuyoshi Nishi; Naoki Kobayashi; Yu Hisano; Atsuo Kawahara; Akihito Yamaguchi
Journal:  Biochim Biophys Acta       Date:  2013-08-04

Review 2.  High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis.

Authors:  Wijtske Annema; Arnold von Eckardstein
Journal:  Circ J       Date:  2013-09-20       Impact factor: 2.993

3.  Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells.

Authors:  Pascale M Ohnsorg; Lucia Rohrer; Damir Perisa; Andreas Kateifides; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis; Arnold von Eckardstein
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Cubilin maintains blood levels of HDL and albumin.

Authors:  Obaidullah Aseem; Brian T Smith; Marion A Cooley; Brent A Wilkerson; Kelley M Argraves; Alan T Remaley; W Scott Argraves
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

5.  Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.

Authors:  Jere P Segrest; Marian C Cheung; Martin K Jones
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

6.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

7.  Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

Authors:  S S Wang; O Devuyst; P J Courtoy; X T Wang; H Wang; Y Wang; R V Thakker; S Guggino; W B Guggino
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 8.  An update on sphingosine-1-phosphate and other sphingolipid mediators.

Authors:  Henrik Fyrst; Julie D Saba
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

Review 9.  Sphingolipids and atherosclerosis.

Authors:  Thorsten Hornemann; Tilla S Worgall
Journal:  Atherosclerosis       Date:  2012-09-29       Impact factor: 5.162

Review 10.  Sphingosine 1-phosphate in renal diseases.

Authors:  Alexander Koch; Josef Pfeilschifter; Andrea Huwiler
Journal:  Cell Physiol Biochem       Date:  2013-05-31
View more
  15 in total

Review 1.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

2.  Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.

Authors:  Mingxia Liu; Jeremy Allegood; Xuewei Zhu; Jeongmin Seo; Abraham K Gebre; Elena Boudyguina; Dongmei Cheng; Chia-Chi Chuang; Gregory S Shelness; Sarah Spiegel; John S Parks
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

Review 3.  Sources, metabolism, and regulation of circulating sphingosine-1-phosphate.

Authors:  Monika Książek; Marta Chacińska; Adrian Chabowski; Marcin Baranowski
Journal:  J Lipid Res       Date:  2015-05-26       Impact factor: 5.922

4.  Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.

Authors:  Srividya Velagapudi; Lucia Rohrer; Francesco Poti; Jerzy-Roch Nofer; Arnold von Eckardstein; Renate Feuerborn; Damir Perisa; Dongdong Wang; Grigorios Panteloglou; Anton Potapenko; Mustafa Yalcinkaya; Andreas J Hülsmeier; Bettina Hesse; Alexander Lukasz; Mingxia Liu; John S Parks; Christina Christoffersen; Markus Stoffel; Manuela Simoni
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-19       Impact factor: 10.514

5.  Resveratrol exerts a biphasic effect on apolipoprotein M.

Authors:  Makoto Kurano; Masumi Hara; Takahiro Nojiri; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  Br J Pharmacol       Date:  2015-11-12       Impact factor: 8.739

6.  Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.

Authors:  Marie-Claude Brulhart-Meynet; Vincent Braunersreuther; Jonas Brinck; Fabrizio Montecucco; Jean-Christophe Prost; Aurelien Thomas; Katia Galan; Graziano Pelli; Sarah Pedretti; Nicolas Vuilleumier; François Mach; Sandrine Lecour; Richard W James; Miguel A Frias
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 7.  A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.

Authors:  Stefan Hajny; Christina Christoffersen
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

Review 8.  Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate.

Authors:  Xi Wang; Fan Wang
Journal:  J Geriatr Cardiol       Date:  2017-11       Impact factor: 3.327

9.  HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Authors:  Anand Rohatgi; Marit Westerterp; Arnold von Eckardstein; Alan Remaley; Kerry-Anne Rye
Journal:  Circulation       Date:  2021-06-07       Impact factor: 39.918

10.  Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes.

Authors:  Pernille M Christensen; Markus H Bosteen; Stefan Hajny; Lars B Nielsen; Christina Christoffersen
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.